At £16.4m, Parkmead is trading at only a small premium to its last reported cash balance of £13m at 30 June 2025. With a further £7m of firm cash payments due into the business over the next 19 months and potential payments of up to a further £120m as a result of the recently completed Serica transaction, Parkmead offers a low-risk investment opportunity with significant upside potential. The Company made strong progress across all elements of its business in 1H25, including delivering solid ope ....
